Dynavax Technologies Corporation Dynavax (NASDAQ: DVAX) Receives Marketing Authorization For HEPLISAV B Dynavax Technologies Corporation (NASDAQ: DVAX) revealed that it has received Marketing Authorization (MA) for HEPLISAV B. DVAX has been awarded this MA after the positive reviews of EMA CHMP.
